Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

As AI shrinks teams, Perplexity's CEO said more entrepreneurs must emerge to create new jobs.

Research leaders from OpenAI, Anthropic, and Google DeepMind are urging tech companies and research groups to monitor AI's ...

In a familiar critique of corporate structures, Musk also weighed in on the ideal environment for fostering such long-term, ...

The move is a bid to catch up with rivals such as OpenAI, Google and Anthropic after the poor performance of the Facebook ...

The researchers argue that CoT monitoring can help researchers detect when models begin to exploit flaws in their training, ...

How many Google AI researchers does it take to screw in a lightbulb? A recent research paper detailing the technical core ...

No AI company scored better than “weak” in SaferAI’s assessment of their risk management maturity. The highest scorer was ...

Demis Hassabis, Google DeepMind's CEO, is being viewed by some within Google as a possible successor to Sundar Pichai.

AI researchers from OpenAI, Google DeepMind and Anthropic and others have urged deeper study into chain-of-thought monitoring ...

After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the ...

Scientists unite to warn that a critical window for monitoring AI reasoning may close forever as models learn to hide their thoughts.